GlassScriptPhysician profile
Wame N Waggenspack
NPI 1003834169
$81,822.18
in general payments reported to CMS, 2019-2025
14 companies · $22K in 2025
The $22K reported for 2025 was more than what 92% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,976 · 2020: $1,469 · 2021: $632 · 2022: $42K · 2023: $11K · 2024: $1,857 · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,585 · Travel and Lodging: $3,073 · Food and Beverage: $2,458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,650.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,585.00 |
| Travel and Lodging | $3,073.13 |
| Food and Beverage | $2,457.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linkbio Corp | $38,287.00 | 2021-2023 | |
| Stryker Corporation | $35,221.06 | 2019-2025 | Blueprint Patient Specific Instrumentation, Aequalis Ascend Flex, Aequalis Perform |
| Smith+Nephew, INC. | $4,349.51 | 2020-2025 | Healicoil, Bone Anchors With Arthroscopic Delivery System, Evos |
| Fx Shoulder Solutions, INC | $1,272.57 | 2019-2025 | |
| Alon Medical Technology | $1,060.20 | 2019-2023 | |
| Arthrex, INC. | $618.17 | 2020 | |
| Encore Medical, LP | $378.29 | 2019 | |
| Integrity Orthopaedics, INC. | $220.69 | 2025 | Integrity Orthopaedics |
| Boston Scientific Corporation | $134.64 | 2021-2023 | |
| Zimmer Biomet Holdings, INC. | $115.38 | 2020 | |
| Mimedx Group, INC. | $84.88 | 2025 | |
| Heron Therapeutics, INC. | $39.10 | 2025 | Zynrelef |
| Ferring Pharmaceuticals INC. | $21.42 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $19.27 | 2025 | Zilretta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wame Waggenspack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.